GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
A study published in Childhood Obesity indicates that nearly 17% of children prescribed GLP-1 medications for weight or diabetes management developed nutritional deficiencies within the first year. Researchers emphasize the need for better nutritional counseling for pediatric patients on these drugs.
Why it matters
As GLP-1 usage grows among youth, identifying and preventing nutritional gaps is vital to ensure healthy development during critical growth stages.
Children taking GLP-1 medications for weight loss, prediabetes, or type 2 diabetes may face an important nutritional concern. A new study published in Childhood Obesity found that nearly one in six young patients (16.8%) were diagnosed with a nutritional deficiency during the first year after starting treatment.
Vitamin D deficiency was the most frequently identified problem, affecting 12.4% of children within one year of beginning GLP-1 therapy.
Nutrition Matters During Childhood Growth
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in